Trigran Investments Inc. Sells 415,296 Shares of Anika Therapeutics Inc. $ANIK

robot
Abstract generation in progress

Trigran Investments Inc. reduced its stake in Anika Therapeutics Inc. (NASDAQ:ANIK) by 20.4% in the third quarter, selling 415,296 shares and now owning 1,621,215 shares valued at $15.2 million. Despite the sell-off, Anika Therapeutics exceeded earnings estimates with $0.31 EPS and $30.62 million in revenue. Institutional ownership of Anika Therapeutics remains high at 91.53%, and analysts currently rate the stock as a “Moderate Buy” with a consensus price target of $19.00.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin